Regencell Bioscience Holdings Ltd (NASDAQ:RGC)
| 26.36 Delayed Data As of 4:00pm ET |  -0.22 / -0.83%Today’s Change | 6.00 Today|||52-Week Range 59.00 | -17.24% Year-to-Date |
Latest RGC News | Press Releases
No recent news for Regencell Bioscience Holdings Ltd.
Today’s Trading
| Previous close | 26.58 |
| Today’s open | 25.72 |
| Day’s range | 25.72 - 26.90 |
| Volume | 927 |
| Average volume (3 months) | 18,956 |
| Market cap | $288.8M |
Data as of 4:00pm ET, 05/24/2022
Growth & Valuation
| Earnings growth (last year) | -65.63% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| No competitors data available. |
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$1.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
